Global Glaucoma Treatment Market: Analysis By Indication, By Drug Class, By Sales Channel, By Region, By Country (2018 Edition)

Date: 10 December 2018

Globally, the market for glaucoma treatment has been growing at a swift pace on the back of rising prevalence of glaucoma, increasing consumer spend on healthcare as well as easy availability of drugs. Apart from these factors, increasing number of ophthalmologist as well as surging number of hospital and retail pharmacies drive the growth of glaucoma treatment market.

According to Azoth Analytics research report “Global Glaucoma Treatment Market -Analysis By Indication, By Drug Class, By Sales Channel, By Region, By Country (2018 Edition): Forecast to 2023 - By Indication (Open Angle, Closed Angle, Secondary, Congenital, Others), By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors)”, global glaucoma treatment market is projected to display a robust growth represented by a CAGR of 4.8% during 2018 – 2023.

The segment of Prostaglandin Analogs witnessed growth at a noteworthy rate over the past few years backed by increased prevalence of glaucoma, easy availability of drugs along with rising number of hospitals and their respective pharmacies. Amongst the regions, North America accounts for the largest regional share in the global glaucoma treatment market in 2018. Key factors driving the robust growth rate of North America region include Well developed healthcare infrastructure, favorable regulatory reforms, rising prevalence of glaucoma in the region.

The report titled “Global Glaucoma Treatment Market: Analysis By Indication, By Drug Class, By Sales Channel, By Region, By Country (2018 Edition): Forecast to 2023 - By Indication (Open Angle, Closed Angle, Secondary, Congenital, Others), By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors)” has covered and analysed the potential of Global Glaucoma Treatment Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global glaucoma treatment market. Additionally, the report also highlights market entry strategies for various companies across the globe. 

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Glaucoma Treatment Market. The report analyzes the global glaucoma treatment market By Indication (Open Angle Glaucoma, Closed Angle Glaucoma, Secondary Glaucoma, Congenital Glaucoma, Others), By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors, Others) and By Sales Channel (Hospital Pharmacy, Retail Pharmacy, Others). The report analyzes the global glaucoma treatment market By Region (North America, Europe, Asia Pacific and Rest of the World) and By Country (U.S., Canada, U.K, Germany, India, China, Japan and Brazil). The report assesses the glaucoma treatment market for the historical period of 2013-2017 and the forecast period of 2018-2023.

...